|
Volumn 40, Issue 3, 2001, Pages 159-168
|
The gut as a barrier to drug absorption: Combined role of cytochrome P450 3A and P-glycoprotein
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ANTIFUNGAL AGENT;
ANTINEOPLASTIC AGENT;
ATORVASTATIN;
CALCIUM CHANNEL BLOCKING AGENT;
CYCLOSPORIN;
CYTOCHROME P450 3A;
DIGOXIN;
ETOPOSIDE;
GLYCOPROTEIN P;
IMMUNOSUPPRESSIVE AGENT;
INDINAVIR;
ITRACONAZOLE;
KETOCONAZOLE;
LIDOCAINE;
MIDAZOLAM;
NELFINAVIR;
PACLITAXEL;
QUINIDINE;
RAPAMYCIN;
RIFAMPICIN;
RITONAVIR;
SAQUINAVIR;
TACROLIMUS;
TALINOLOL;
UNINDEXED DRUG;
VINBLASTINE;
VINCRISTINE;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG METABOLISM;
ENZYME SPECIFICITY;
HUMAN;
INTESTINE ABSORPTION;
INTESTINE CELL;
INTESTINE VILLUS;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
REVIEW;
|
EID: 0035054725
PISSN: 03125963
EISSN: None
Source Type: Journal
DOI: 10.2165/00003088-200140030-00002 Document Type: Review |
Times cited : (512)
|
References (5)
|